Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804

CONCLUSION: RT significantly reduced all and invasive IBR for good-risk DCIS with durable results at 15 years. These results are not an absolute indication for RT but rather should inform shared patient-physician treatment decisions about ipsilateral breast risk reduction in the long term following lumpectomy.PMID:34406870 | DOI:10.1200/JCO.21.01083

Source: Clinical Breast Cancer - August 18, 2021 Category: Cancer & Oncology Authors: Beryl McCormick Kathryn A Winter Wendy Woodward Henry M Kuerer Nour Sneige Eileen Rakovitch Barbara L Smith Isabelle Germain Alan C Hartford Mark A O'Rourke Eleanor M Walker Eric A Strom Judith O Hopkins Lori J Pierce Anthony T Pu Kenneth N M Sumida Danny Source Type: research